BioCentury
ARTICLE | Company News

Management tracks: NGM, TMC Innovation Institute, Lexent

March 20, 2019 10:18 PM UTC

Liver disease and metabolic company NGM said CMO Alex DePaoli will become SVP, chief translational officer. NGM Biopharmaceuticals Inc. (South San Francisco, Calif.) also hired Hsiao Lieu as SVP, CMO. Lieu was VP of early clinical development at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY).

TMC Innovation Institute (Houston, Texas) said Erik Halvorsen was succeeded by Thomas Luby as the institute's director. Luby was head of JLABS @ TMC, Johnson & Johnson Innovation LLC's Texas Medical Center incubator...